A new generic version of the popular and controversial birth control pill Yaz has finally hit the market. This generic version is called Loryna, and it is manufactured by the company called Sandoz.
The generic version of Yaz was recently approved by the Food and Drug Administration (FDA) despite the thousands of lawsuits against the makers of the brand name version. This copy is the second generic Yaz that will be widely available in the U.S. The first generic version was called Gianvi, and was launched by Teva Pharmaceuticals in June 2010. While Loryna won’t actually hit the shelves for a couple more weeks, it is expected to cause the same serious side effects that have plagued Yaz and Yasmin.
Loryna also contains the same combination of synthetic hormones like drospirenone and ethinyl estradiol. The drug will also be given in the exact same way under the same dosages as the name brand version of Yaz. It is more than likely that the generic version will cause such severe side effects as blood clots that can lead to strokes, pulmonary embolism and deep vein thrombosis, as well as gallbladder disease and even death.
There are many lawsuits that have been filed against other birth control pills that are similar to Yaz in their make ups as well. Yasmin, which is very much like Yaz and also contains drosperinone, has been named in hundreds of lawsuits. Some other oral contraceptives that have been named in lawsuits include Ocella and Zarah, which are both generic versions of Yasmin.
Safyral and Beyaz, which are being touted by Bayer as the healthier oral contraceptives that were made to include metafolin (folic acid) as helping reduce the rate of birth defects for babies of mother who get pregnant immediately after taking the pills, also have been included in the Yasmin lawsuits.
